Is an AICD a Pacemaker? Key Differences Explained

An AICD, more commonly called an ICD (implantable cardioverter-defibrillator), is not a pacemaker, though the confusion is understandable because modern ICDs can do everything a pacemaker does and more. The core difference is purpose: a pacemaker sends small electrical pulses to keep a heart that beats too slowly on track, while an ICD monitors for dangerously fast or chaotic rhythms and delivers a shock to reset them. Think of a pacemaker as a metronome that keeps the beat steady, and an ICD as a defibrillator that lives inside your chest, ready to jolt the heart back to normal if it suddenly spirals out of control.

What Each Device Actually Does

A pacemaker’s job is straightforward. When the heart’s natural electrical system fails to fire properly or conducts signals too slowly, a pacemaker steps in with tiny electrical impulses that prompt the heart muscle to contract. These impulses are so small you cannot feel them. The device was originally developed in the mid-twentieth century as large external equipment; technological advances eventually made it fully implantable, and more recently, leadless versions that sit entirely inside the heart have arrived.¹ People who need pacemakers typically have conditions where the heart beats too slowly, pauses for too long, or has electrical blockages between its upper and lower chambers.

An ICD does something fundamentally different. It continuously watches the heart’s rhythm, and if it detects a life-threatening arrhythmia like ventricular tachycardia or ventricular fibrillation, it intervenes. That intervention can be a high-energy shock, which feels like a sudden thump or kick in the chest, or a series of rapid low-energy pacing pulses designed to outpace and terminate the abnormal rhythm before a shock becomes necessary. The device exists because these fast, chaotic rhythms can cause the heart to stop pumping blood within seconds, leading to sudden cardiac death if nothing interrupts them.

Here is where the overlap creates confusion: virtually every modern ICD also includes full pacemaker functionality. If your heart rate drops too low, the ICD can pace it just like a standalone pacemaker would. But a standalone pacemaker cannot deliver the high-energy shocks needed to terminate a lethal arrhythmia. So while an ICD can substitute for a pacemaker, a pacemaker cannot substitute for an ICD.

Why Doctors Choose One Over the Other

The conditions that call for a pacemaker versus an ICD are quite different, even though both involve the heart’s electrical system. Pacemakers are prescribed for people whose hearts beat too slowly or whose electrical signals get stuck somewhere in the conduction pathway. This includes conditions like sick sinus syndrome, complete heart block, and certain inherited disorders. In some rare neuromuscular conditions, doctors may implant a pacemaker as a preventive measure because the conduction system is expected to deteriorate over time.²

ICDs, on the other hand, are for people at high risk of sudden cardiac death from dangerously fast heart rhythms. The most common scenario is someone with heart failure and a weakened pumping function. ICD therapy is indicated in a subset of patients with heart failure and reduced ejection fraction as primary prevention against sudden cardiac death.³ “Primary prevention” means the person has never actually had a cardiac arrest but is statistically at high enough risk that the device is placed preemptively. ICDs are also used as “secondary prevention” in people who have already survived a cardiac arrest or a documented episode of sustained ventricular tachycardia.

Some patients need both functions. A person with heart failure may have a slow resting heart rate that requires pacing support and also be at risk for sudden lethal arrhythmias. In that case, a single ICD handles both jobs. This dual capability is one reason people casually refer to their ICD as “my pacemaker,” which reinforces the confusion.

How an ICD Stops a Dangerous Rhythm

When most people picture an ICD at work, they imagine the shock: a sudden jolt that resets the heart. That does happen, but modern ICDs try hard to avoid it. The shock is painful, startling, and associated with worse outcomes for patients who receive them frequently. Large-scale ICD trials have consistently shown a strong association between shocks and increased mortality in ICD recipients, though researchers debate whether the shocks themselves cause harm or simply flag patients with more severe underlying disease.⁴

The preferred first-line response for many fast rhythms is antitachycardia pacing, or ATP. Instead of delivering a painful shock, the ICD fires a rapid burst of small pacing pulses that are timed to interrupt and reset the abnormal circuit driving the arrhythmia. ATP has gained increasing importance in treating ventricular arrhythmias because it reduces unnecessary and inappropriate shocks and improves both quality of life and device battery longevity.⁵ You generally cannot feel ATP the way you feel a shock. For many patients, the device terminates a dangerous rhythm quietly, without them ever knowing it happened.

The clinical difference between receiving ATP versus shocks is meaningful beyond comfort. Among patients with ICDs implanted for primary prevention, those who received only ATP therapy had reduced hospitalizations, lower mortality, and lower healthcare costs compared with patients who received at least one high-energy shock. In fact, their outcomes were equivalent to patients whose devices never needed to fire at all.⁶ This is why doctors invest significant effort in programming the device to attempt ATP before resorting to a shock whenever the rhythm allows it.

How ICDs Tell Good Rhythms From Bad Ones

A tricky engineering challenge for ICDs is distinguishing a genuinely dangerous ventricular arrhythmia from a fast but non-lethal rhythm originating higher in the heart. If the ICD cannot tell the difference, it may deliver an inappropriate shock for something like a rapid heartbeat during exercise or an episode of atrial fibrillation. Inappropriate shocks are one of the most-discussed complications of ICD therapy because they are painful and psychologically distressing without providing any benefit.

Modern ICDs use sophisticated algorithms that analyze both the timing of heartbeats and the shape of the electrical signal to classify what the heart is doing. Some devices use vector timing and correlation algorithms that compare each heartbeat’s electrical signature against a stored template of the patient’s normal rhythm to identify rhythms that originate from the ventricles rather than the upper chambers.⁷ Dual-chamber ICDs, which have leads in both the upper and lower chambers, have an additional advantage because they can directly compare what the atria and ventricles are doing. If both chambers are racing at the same rate, the rhythm is more likely supraventricular (originating above) and therefore not typically life-threatening.

Pacemakers also sense the heart’s activity, but their sensing job is simpler. A pacemaker mostly needs to know whether the heart has beaten recently so it can decide whether to deliver a pacing pulse. It does not need the kind of complex rhythm classification an ICD performs, because it is not making high-stakes decisions about whether to shock.

Battery Life and Replacement

Both pacemakers and ICDs run on sealed batteries that cannot be recharged. When the battery runs low, the entire device (called the generator) is surgically replaced in a procedure that is less involved than the original implant because the leads already in the heart can usually stay in place. Battery life is an important practical difference between the two devices.

Pacemakers generally last longer because they deliver only tiny pacing pulses that draw minimal power. Many modern pacemakers last well over a decade. ICDs use more energy, especially when they deliver shocks. A real-world analysis of a prospective ICD database found an overall median battery life of about 10.8 years, with roughly 98% of single- and dual-chamber ICDs still in service after five years and about 94% of single-chamber units still running at seven years.⁸ That said, individual battery life varies depending on how often the device needs to pace or shock, how it is programmed, and which manufacturer made it.

Generator replacement carries its own risks. In a large registry study, major complications occurred in about 4% of straightforward generator replacements but jumped to over 15% when the procedure involved adding or revising leads, and the highest complication rates (approaching 19%) were seen in patients whose devices were upgraded to more complex systems. ICD replacements consistently carried higher complication rates than pacemaker replacements.⁹ Six-month infection rates in that registry hovered around 1 to 1.5% regardless of the type of procedure, a small but real risk given that an infected device usually has to be completely removed.

MRI Safety

One of the most common questions people with cardiac devices ask is whether they can have an MRI. For years, having any implanted cardiac device was considered an absolute contraindication for MRI because the scanner’s powerful magnetic field could theoretically heat leads, move the generator, or cause the device to malfunction. The situation has evolved considerably.

In vitro and animal testing demonstrated that modern devices manufactured after 2000 tolerated MRI scans at 1.5 Tesla without damage or dysfunction, while older ICDs made before 2000 were damaged by the scans.¹⁰ Building on this, a large clinical study examined MRI safety in patients with both pacemakers and ICDs. Before scanning, the devices were reprogrammed: pacing-dependent patients had their pacemaker mode changed to prevent the MRI from inhibiting pacing, and the shock function (tachyarrhythmia therapy) on ICDs was turned off during the scan so the device would not misinterpret MRI signals as a dangerous rhythm and deliver an inappropriate shock.¹¹

Today, many pacemakers and ICDs are specifically labeled as MRI-conditional, meaning they have been tested and approved for use in an MRI under defined conditions. Even devices not officially labeled MRI-conditional can often be scanned safely at experienced centers with proper device reprogramming and monitoring. The key point for patients is that having an ICD or pacemaker no longer automatically rules out MRI, but it does require coordination between your cardiologist and the imaging center.

Driving and Daily Life

Living with a pacemaker versus an ICD imposes different restrictions on daily activities, and driving is the area where the gap is most noticeable. Pacemaker recipients generally face minimal driving restrictions after the initial healing period. The device simply keeps the heart rate from dropping too low, and that function is unlikely to cause sudden incapacitation while driving.

ICD patients face a more complicated picture. The underlying conditions that necessitate an ICD carry an ongoing risk of sudden incapacitation, and ICD shocks themselves can be disorienting or briefly disabling. Guidelines on when ICD patients can resume driving vary by country and even by state, and there is considerable disagreement among experts about the appropriate waiting period after an ICD is implanted or after the device delivers therapy.¹² In many jurisdictions, patients are advised to avoid driving for several months after initial ICD implantation and for a period after any shock episode. Commercial driving with an ICD is restricted or prohibited in most places.

Beyond driving, both devices impose similar precautions around strong magnetic fields and certain types of equipment. You should keep cell phones and smartwatches a few inches from the device, avoid lingering near anti-theft gates in stores, and inform medical staff about your device before any procedure. ICD patients have the additional consideration of shock anxiety, a well-recognized psychological burden where the fear of being shocked affects quality of life even in patients who have never been shocked. This is something pacemaker patients rarely experience because their device does not deliver painful therapy.

Combination Devices and Newer Technology

Not all cardiac devices fit neatly into the “pacemaker or ICD” binary. Cardiac resynchronization therapy (CRT) devices are designed for patients with heart failure whose ventricles do not contract in sync. A CRT device paces both ventricles simultaneously to coordinate the heartbeat, which can improve the heart’s pumping efficiency and reduce symptoms. CRT devices come in two flavors: CRT-P (with pacemaker function only) and CRT-D (with built-in defibrillator capability). The choice between them depends on whether the patient also needs protection against sudden cardiac death, and that decision is not always straightforward.

On the frontier of device technology, leadless pacemakers and subcutaneous ICDs represent two parallel innovations that are now being combined. A leadless pacemaker is a self-contained capsule implanted directly inside the heart, eliminating the traditional leads that run through veins. A subcutaneous ICD sits just under the skin of the chest with its lead tunneled under the skin rather than threaded into the heart. Both designs avoid some of the lead-related complications that plague traditional systems, like lead fracture and vein obstruction. Researchers have demonstrated workflows for implanting both devices in the same patient, using the leadless pacemaker for bradycardia support and the subcutaneous ICD for defibrillation, with intraoperative screening to ensure the two devices work together without interfering.¹³ These combined systems are still relatively new, but they point toward a future where the hardware distinctions between pacemakers and ICDs become even more blurred.

The Cost Gap

ICDs are substantially more expensive than pacemakers, and the cost difference extends well beyond the price of the device itself. The generator is more complex, the implant procedure is longer, and follow-up care is more intensive because ICD patients need regular device interrogations to review any detected arrhythmias and adjust programming.

A landmark cost-effectiveness analysis from the late 1990s estimated accumulated costs of about $97,560 for ICD patients compared with roughly $75,980 for patients treated with medication alone, yielding a cost of about $27,000 per additional year of life saved.¹⁴ Those numbers are dated, but a broader analysis across eight major ICD trials found that the cost-effectiveness ratio ranged from about $34,000 to $70,200 per quality-adjusted life-year gained, depending on the patient population. Two of the eight trials studied actually found that ICDs provided no mortality benefit at all in their specific populations, making the devices both more expensive and less effective than medication alone in those groups.¹⁵ The sensitivity analyses showed that ICD cost-effectiveness remained below $100,000 per quality-adjusted life-year as long as the mortality benefit persisted for at least seven years.

These figures underline an important point: ICDs are a proven, worthwhile investment in carefully selected patients, but not every patient at some theoretical risk of sudden death benefits. Patient selection matters enormously, and the guidelines that govern who receives an ICD have been refined repeatedly to ensure that the devices go to people most likely to benefit.

The Origin Story

The ICD’s path to acceptance was rockier than the pacemaker’s. Pacemakers were a relatively intuitive solution to a well-understood problem: the heart beats too slowly, so you provide an electrical stimulus. The ICD, by contrast, was a radical idea when Michel Mirowski and Morton Mower first proposed it in the late 1960s. The notion that you could implant a device capable of detecting and automatically treating a lethal arrhythmia was met with skepticism and outright criticism from much of the medical establishment.¹⁶ The first human ICD implant occurred in 1980, and the early devices required open-chest surgery to attach patches directly to the heart. Over more than 35 years of engineering refinement, the devices shrank from the size of a large deck of cards to something comparable to a matchbox, leads moved from surgical patches to transvenous wires threaded through veins, and the algorithms grew sophisticated enough to distinguish benign fast rhythms from deadly ones with reasonable accuracy.

The term “AICD” itself is a relic of this history. It originally stood for “Automatic Implantable Cardioverter-Defibrillator” and was actually a brand name used by the device’s original manufacturer. Clinicians now prefer “ICD” as the generic term, but “AICD” stuck in patient vocabulary and is still widely used in conversation and internet searches. If your doctor calls your device an ICD rather than an AICD, they are talking about the same thing.